BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36869967)

  • 1. A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt
    Chiaverini L; Baglini E; Mannelli M; Poggetti V; Da Settimo F; Taliani S; Gamberi T; Barresi E; La Mendola D; Marzo T
    Biometals; 2023 Oct; 36(5):961-968. PubMed ID: 36869967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues.
    Cirri D; Geri A; Massai L; Mannelli M; Gamberi T; Magherini F; Becatti M; Gabbiani C; Pratesi A; Messori L
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties.
    Landini I; Massai L; Cirri D; Gamberi T; Paoli P; Messori L; Mini E; Nobili S
    J Inorg Biochem; 2020 Jul; 208():111079. PubMed ID: 32497830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold Nanoclusters as Nanoantibiotic Auranofin Analogues.
    Ndugire W; Raviranga NGH; Lao J; Ramström O; Yan M
    Adv Healthc Mater; 2022 May; 11(9):e2101032. PubMed ID: 34350709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.
    Feng L; Pomel S; Latre de Late P; Taravaud A; Loiseau PM; Maes L; Cho-Ngwa F; Bulman CA; Fischer C; Sakanari JA; Ziniel PD; Williams DL; Davioud-Charvet E
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33139647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin.
    Cirri D; Fabbrini MG; Massai L; Pillozzi S; Guerri A; Menconi A; Messori L; Marzo T; Pratesi A
    Biometals; 2019 Dec; 32(6):939-948. PubMed ID: 31686259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
    Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
    J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety.
    Ronga L; Tolbatov I; Giorgi E; Pisarek P; Enjalbal C; Marrone A; Tesauro D; Lobinski R; Marzo T; Cirri D; Pratesi A
    Inorg Chem; 2023 Jul; 62(26):10389-10396. PubMed ID: 37342994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
    Prast-Nielsen S; Cebula M; Pader I; Arnér ES
    Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
    Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
    Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent.
    Cirri D; Massai L; Giacomelli C; Trincavelli ML; Guerri A; Gabbiani C; Messori L; Pratesi A
    Dalton Trans; 2022 Sep; 51(35):13527-13539. PubMed ID: 36000524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the Potential of Innovative Gold(I) and Silver(I) Selenourea Complexes as Anticancer Agents Targeting TrxR and Cellular Redox Homeostasis.
    De Franco M; Saab M; Porchia M; Marzano C; Nolan SP; Nahra F; Van Hecke K; Gandin V
    Chemistry; 2022 Dec; 28(70):e202201898. PubMed ID: 36106679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
    Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
    J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma.
    Sze JH; Raninga PV; Nakamura K; Casey M; Khanna KK; Berners-Price SJ; Di Trapani G; Tonissen KF
    Redox Biol; 2020 Jan; 28():101310. PubMed ID: 31514052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Anticancer Activity of Auranofin.
    Onodera T; Momose I; Kawada M
    Chem Pharm Bull (Tokyo); 2019; 67(3):186-191. PubMed ID: 30827998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
    Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
    J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells.
    Marzano C; Gandin V; Folda A; Scutari G; Bindoli A; Rigobello MP
    Free Radic Biol Med; 2007 Mar; 42(6):872-81. PubMed ID: 17320769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potential Anticancer Activity of Auranofin].
    Momose I; Onodera T; Kawada M
    Yakugaku Zasshi; 2021; 141(3):315-321. PubMed ID: 33642497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.